Join us as Derek Chu, MD, PhD, explores the paradigm shift in treating atopic dermatitis as a systemic, immune-driven disease rather than a localized skin condition. We discuss the updates to the practice parameters including practical guidance on integrating of novel topicals, biologics, and JAK inhibitors into our treatment as well as the upcoming practice parameters on chronic spontaneous urticaria. 

Continuing Medical Education credit is available with this episode. Complete the assessment and claim credit. .75 AMA PRA Category 1 Credit(s)™ 

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The American Academy of Allergy, Asthma & Immunology (AAAAI). Innehållet i podden är skapat av The American Academy of Allergy, Asthma & Immunology (AAAAI) och inte av, eller tillsammans med, Poddtoppen.